Eli Lilly and Company (LLY) vs Exxon Mobil Corporation (XOM)
See how Eli Lilly and Company and Exxon Mobil Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$160.95
NYSE
Exxon Mobil Corporation is an integrated oil and gas company engaged in the global exploration, production, and refining of petroleum. In 2025, the company produced 3.3 million barrels of liquids per day and 8.4 billion cubic feet of natural gas daily. As of the end of 2025, ExxonMobil reported 19.3 billion barrels of oil equivalent in reserves, with liquids accounting for 69% of the total. The company is also among the world’s largest refiners, with total global refining capacity of 4.1 million barrels of oil per day, and ranks as a leading producer of both commodity and specialty chemicals.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Exxon Mobil CorporationXOM
Market Cap$661.812B
Price$160.95
24h Change+2.71%
24h Volume$17.99M
Employees57,900
Shares Outstanding4,156,559,415
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
60.9%XOM
39.1%Volume Share
Share of combined 24h volume
LLY
14.4%XOM
85.6%24h Performance
Price change over last 24 hours
LLY
-1.52%XOM
2.71%Price Comparison
Eli Lilly and Company
Exxon Mobil Corporation